Back to home
ZBH logo

Is ZBH (Zimmer Biomet Holdings, Inc.) Halal or Haram?

New York Stock ExchangeHealthcareMedical - Devices$15.68B2026-04-29
ZBH is Doubtful3/4 screens passed

While Zimmer Biomet's core medical device business is shariah-compliant, the stock currently fails the AAOIFI financial screens due to excessive leverage. Specifically, its debt-to-market cap ratio sits at 47.9%, well above the 33% threshold, rendering the stock doubtful for halal portfolios despite its clean interest income ratio of 0.00%.

Price Chart (5D)

$88.62+5.73 (+6.91%)
2026-06-092026-06-01

ZBH — Last 7 Days

DateOpenHighLowCloseVolumeChange
2026-06-0987.7289.1087.4488.65516K+1.06%
2026-06-0887.4088.3586.7487.271.6M-0.15%
2026-06-0587.6088.7886.5387.332.0M-0.31%
2026-06-0486.5088.3786.1386.691.6M+0.22%
2026-06-0383.6485.6083.5184.981.9M+1.60%
2026-06-0282.8084.7882.1783.752.6M+1.15%
2026-06-0182.4483.6581.6282.942.7M+0.61%

Discussion

Sign in to join the discussion

Loading comments...

Shariah Screening Details for ZBH

Business Activity

Permissible

Zimmer Biomet passes the business activity screen because manufacturing orthopaedic reconstructive products, spine devices, and musculoskeletal healthcare solutions is fully permissible and highly beneficial under Islamic principles.

Debt / Market Cap

47.94%

Debt: $7.52BThreshold: ≤33%

Interest Income

0.00%

Interest: $0Threshold: ≤5%

Cash & Securities

3.77%

Cash: $591.9MThreshold: ≤33%

About Zimmer Biomet Holdings, Inc. (ZBH)

Zimmer Biomet Holdings, Inc. is a global leader in musculoskeletal healthcare, designing and manufacturing orthopaedic reconstructive products. The company's extensive portfolio includes knee and hip replacements, sports medicine biologics, and advanced spine and facial reconstruction devices used by medical professionals worldwide.

For Muslim investors using AAOIFI standards, Zimmer Biomet is currently classified as doubtful. While the company's life-enhancing medical devices easily pass the business activity screen, it unfortunately fails the financial screening due to a high debt-to-market capitalization ratio.

The primary concern from an Islamic finance perspective is ZBH's reliance on interest-bearing debt, which accounts for 47.9% of its market cap, exceeding the 33% maximum limit. On a positive note, the company maintains excellent liquidity metrics, with cash and securities at just 3.8% and an interest income ratio of 0.00%.

Since the core business is highly permissible and beneficial, halal investors should keep Zimmer Biomet on their watchlists. If the company actively pays down its debt or if its market capitalization increases enough to bring the debt ratio below 33%, it could become a viable shariah-compliant investment in the future.

CEO

Ivan Tornos

Employees

17,000

IPO Date

2001-07-25

Headquarters

Warsaw, IN, US

ZBH Key Financial Statistics

Revenue

$8.23B

Net Income

$705.2M

EPS (Diluted)

$3.55

Stock Price

81.02

Beta

0.62

52-Week Range

80.96-108.29

Total Debt

$7.52B

Total Equity

$12.71B

Current Ratio

1.98

ZBH Financial Health & Profitability

Profit Margins

Gross Margin61.6%
Operating Margin16.5%
Net Margin8.6%

Revenue Growth (YoY)

+7.2%

Prior year: $7.68B

Net Debt

$6.93B

Cash: $591.9M — Debt: $7.52B

R&D Spending

$458.5M

% of Revenue

5.6%

Frequently Asked Questions About ZBH

Is ZBH (Zimmer Biomet Holdings, Inc.) stock halal to invest in?
Based on our AAOIFI-standard shariah screening, ZBH is classified as Doubtful. It passed 3 of 4 compliance screens. Some scholars may permit investing with income purification, while others advise avoiding it. We recommend consulting a qualified Islamic scholar before investing in ZBH.
What does Zimmer Biomet Holdings, Inc. do?
Zimmer Biomet Holdings, Inc. is a global leader in musculoskeletal healthcare, designing and manufacturing orthopaedic reconstructive products. The company's extensive portfolio includes knee and hip replacements, sports medicine biologics, and advanced spine and facial reconstruction devices used by medical professionals worldwide. For Muslim investors using AAOIFI standards, Zimmer Biomet is currently classified as doubtful. While the company's life-enhancing medical devices easily pass the business activity screen, it unfortunately fails the financial screening due to a high debt-to-market capitalization ratio. The primary concern from an Islamic finance perspective is ZBH's reliance on interest-bearing debt, which accounts for 47.9% of its market cap, exceeding the 33% maximum limit. On a positive note, the company maintains excellent liquidity metrics, with cash and securities at just 3.8% and an interest income ratio of 0.00%. Since the core business is highly permissible and beneficial, halal investors should keep Zimmer Biomet on their watchlists. If the company actively pays down its debt or if its market capitalization increases enough to bring the debt ratio below 33%, it could become a viable shariah-compliant investment in the future. Zimmer Biomet Holdings, Inc. operates in the Healthcare sector under the Medical - Devices industry and is headquartered in Warsaw, IN, US. The company is led by CEO Ivan Tornos and employs approximately 17,000 people.
What screening criteria were used for ZBH?
ZBH was screened using AAOIFI-based shariah compliance criteria. Four tests are applied: (1) Business Activity — the company's core business must not derive primary income from haram (prohibited) activities such as alcohol, gambling, tobacco, or interest-based finance. (2) Debt-to-Market-Cap — total debt must not exceed 33% of market capitalization. (3) Interest Income — interest income must not exceed 5% of total revenue. (4) Cash & Securities — cash and interest-bearing securities must not exceed 33% of market cap. ZBH passed 3 of these 4 screens.
When was ZBH last screened?
ZBH was last screened on 2026-04-29. Shariah compliance status can change as companies report new financial data, acquire new businesses, or shift revenue streams. We recommend checking back periodically for the most up-to-date screening results.

Disclaimer

This shariah compliance assessment for ZBH (Zimmer Biomet Holdings, Inc.) is provided for informational purposes only and does not constitute financial, investment, or religious advice. Screening criteria are based on widely accepted AAOIFI standards, but individual scholars may differ in their opinions. Always consult with a qualified Islamic scholar and licensed financial advisor before making investment decisions. Past screening status does not guarantee future compliance. Last screened: 2026-04-29.

Other Screened Stocks in Healthcare